Newsletter

Numbers Out Making Noise Before the Opening Bell

GlobalSCAPE, Inc. (GSB)

After closing bell on Tuesday's trading session, GSB reported strong earnings growth on its financial results, driven by increased revenue combined with lower operating expenses.

For the third quarter 2013, GSB posted revenue of $6.3 million, a 3% increase year over year, and net income of $2.3 million or $0.12 per share, compared to a net loss of $2.7 million, or ($0.15) per share, in the same period the prior year.

GSB ensures the reliability of mission-critical operations by securing sensitive data and intellectual property. GSB’s suite of solutions features EFT Server, the industry-leading enterprise file transfer solution that delivers military-grade security and a customizable platform for achieving best in class control and visibility of data in motion or at rest, across multiple locations.

More about GlobalSCAPE, Inc. (GSB) at www.globalscape.com

**

Sinovac Biotech Ltd. (SVA)

SVA reported on its unaudited financial results another strong quarter with revenue growth, which resulted in another profitable quarter on a sequential quarterly basis.

For the third quarter 2013, SVA posted total sales of $22.1 million, a 54.5% increase year over year, gross profit of $15.9 million, a 111.7% increase compared to the same period the prior year, and net income attributable to common stockholders of $2.3 million, or $0.04 per basic and diluted share, compared to net loss of $3.0 million, or ($0.05) per basic and diluted share in the third quarter 2012.

SVA is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu) and mumps, as well as animal rabies vaccine for canines.

More about Sinovac Biotech Ltd. (SVA) at www.sinovac.com

**

General Disclaimer: Statements on this website or newsletter may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company’s future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company’s partners that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company’s filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained on this website. The Company disclaims any obligation to update any statements in this website. These stock quotes and related data are provided for information purposes only and are not intended for trading purposes. Crown Equity Holdings Inc. will not be liable for any inaccuracies or delays in such data, or for any actions taken in reliance thereon. Potential investors should seek independent information and advice from qualified investment professionals prior to investment. Crown Equity Holdings Inc. provides links to websites operated by third parties. These links may be of interest or of use to you, and are provided for convenience only. You should be aware that in using these links, you are leaving Crown Equity Holdings Inc’s website. Crown Equity Holdings Inc. does not approve or endorse the content, information or materials available on such third party websites. In addition, Crown Equity Holdings Inc. makes no representation regarding, and is not responsible for, the content, information or material available on such websites. If you decide to access such websites or newsletter you do this at your own risk, and Crown Equity Holdings Inc. will not be liable for any loss or damage associated with your use of, or reliance on, the content, information or material available on such website.